[{"NetIncomeLoss_3_Q3_USD":-3716000.0,"InterestAndOtherIncome_1_Q3_USD":7000.0,"InterestAndOtherIncome_3_Q3_USD":106000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":346000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":558000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":360000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":107000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q3_USD":86000.0,"AssetsCurrent_0_Q3_USD":25071000.0,"CommonStockSharesIssued_0_Q3_shares":25578673.0,"Assets_0_Q3_USD":25399000.0,"ShareBasedCompensation_3_Q3_USD":750000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":316000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":-2000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":102000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":24745000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":24972000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":2634000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":-219000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"CommonStockValue_0_Q3_USD":26000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":729000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":21000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":22000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":4840000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":45000.0,"OtherAssetsCurrent_0_Q3_USD":997000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":12000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":24074000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":258000.0,"Liabilities_0_Q3_USD":1426000.0,"OperatingLeaseLiability_0_Q3_USD":316000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"GeneralAndAdministrativeExpense_1_Q3_USD":1038000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":20000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":336000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":36000.0,"OperatingIncomeLoss_1_Q3_USD":-1437000.0,"ProceedsFromWarrantExercises_3_Q3_USD":4584000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":66000.0,"LiabilitiesCurrent_0_Q3_USD":1168000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":993000.0,"AccountsPayableCurrent_0_Q3_USD":465000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":997000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":256000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-4207000.0,"ProceedsFromStockOptionsExercised_1_Q3_USD":256000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":23973000.0,"LesseeOperatingLeaseDiscountRate_0_Q3_pure":0.0325,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":71105.0,"PrepaidInsurance_0_Q3_USD":686000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":12000.0,"NetIncomeLoss_1_Q3_USD":-1430000.0,"AdditionalPaidInCapital_0_Q3_USD":196250000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q3_USD":null,"ProceedsFromSaleOfPropertyPlantAndEquipment_3_Q3_USD":360000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":878000.0,"OperatingIncomeLoss_3_Q3_USD":-3822000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":25399000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":80000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":228000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":750000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":892000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":58000.0,"OperatingExpenses_3_Q3_USD":3822000.0,"OperatingExpenses_1_Q3_USD":1437000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-0.15,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.06,"OtherLiabilitiesCurrent_0_Q3_USD":7000.0,"StockholdersEquity_0_Q3_USD":23973000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-172303000.0,"CommonStockSharesOutstanding_0_Q3_shares":25578673.0,"CommonStockSharesAuthorized_0_Q3_shares":120000000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":25000.0,"Ticker":"SAVA","CIK":"1069530","name":"CASSAVA SCIENCES INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]